Penbutolol overdosage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Penbutolol}} {{CMG}}; {{AE}} {{SS}} ==Overdosage== There is no actual experience with levatol® overdose. The signs and symptoms that would be expected with over...")
 
(Redirected page to Penbutolol#Overdosage)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Penbutolol#Overdosage]]
{{Penbutolol}}
{{CMG}}; {{AE}} {{SS}}
 
==Overdosage==
 
There is no actual experience with levatol® overdose. The signs and symptoms that would be expected with overdosage of ß-adrenergic receptor antagonists are symptomatic [[bradycardia]], [[hypotension]], bronchospasm, and acute cardiac failure. In addition to discontinuation of levatol®, gastric emptying, and close observation of the patient, the following measures might be considered as appropriate:
 
Excessive [[bradycardia]]: Administer atropine sulfate to induce vagal blockade. If [[bradycardia]] persists, intravenous [[isoproterenol]] hydrochloride may be administered cautiously; larger than usual doses may be needed. In refractory cases, the use of a transvenous cardiac pacemaker may be necessary.
 
[[hypotension]]: Sympathomimetic drug therapy, such as [[dopamine]], [[dobutamine]], or [[levarterenol]], may be considered if [[hypotension]] persists despite correction of [[bradycardia]]. In refractory cases, administration of glucagon hydrochloride has been reported to be useful.
 
Bronchospasm: A ß-2-agonist or [[isoproterenol]] hydrochloride may be administered. Additional therapy with [[aminophylline]] may be considered.
 
Acute Cardiac Failure: Institute conventional therapy immediately. Intravenous administration of [[dobutamine]] and glucagon hydrochloride has been reported to be useful.
 
Heart Block (Second or Third Degree): [[isoproterenol]] hydrochloride or a transvenous cardiac pacemaker may be used.
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LEVATOL (PENBUTOLOL SULFATE) TABLET [ACTIENT PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d241fc80-2c55-4dbb-bdb2-44f731afa137 | publisher =  | date =  | accessdate = 4 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Beta blockers]]
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 00:01, 22 July 2014